It is no surprise that companies operating in Canada have been venturing aggressively into the cannabis space. With only a few weeks before the product is federally legalized and therefore made commercially viable for most entities, cannabis is promising investors a high return while operating within a well-established market. Upon this backdrop, Trulieve Cannabis (CNSX:TRUL) is therefore poised for growth.

"Going green" has taken on an entirely new meaning in 2018. In just nine days, on Oct. 17, 2018, Canada will be lifting the curtain on more than nine decades of cannabis prohibition. Beginning next Wednesday, adults aged 18 or 19 (depending on the province) will be free to purchase recreational marijuana in licensed dispensaries or online. It'll also make Canada the first industrialized country in the world, and only second overall behind Uruguay, to legalize recreational weed.

Yannick Craigwell doesn’t need to guess how large the Canadian appetite will be for edible pot once it’s legal. He already knows that it’s huge.

The Vancouver entrepreneur whips up marijuana-infused cookies, brownies and fudge that he sells online through his company Treats and Treats.

“Once it becomes legal, I think the only thing that’s going to change is you’re going to get the people who were raised to think ... ‘Weed is bad, it’s the devil’s lettuce,’ and they’re going to be open to trying,” he said.

“It’s not really anything to be afraid of, but we are stigmatized by the laws that we have on the books.”

When it comes to cannabis stocks, the public can't get enough. After years of challenging access to capital, 2018 has seen a remarkable improvement for U.S. cannabis operators. In the summer, two leading companies went public, MedMen and Green Thumb Industries. Both stocks have performed well, and each of the companies has subsequently priced secondary offerings, raising additional capital to fund acquisitions and capital expenditures. Aurora Cannabis spin-out Australis Capital soared in its trading initially and still trades at a substantial premium to the level at which it issued a private placement just before its debut in mid-September.

Everything has looked up for HEXO Corp.(NASDAQOTH:HYYDF) so far this year. Its stock has soared nearly 80%, making HEXO one of the best-performing Canadian marijuana stocks. Things haven’t been too shabby for CannTrust Holdings (NASDAQOTH:CNTTF), either. Its stock is up more than 30%.But which of these marijuana stocks is the better pick for investors now? Here’s how HEXO and CannTrust stack up against each other.

The countdown is on.

In just 10 days, the global cannabis industry will be dramatically reshaped. On Oct. 17, Canada opens the market for the legal adult use of recreational marijuana.

The impact from the first major economic power to allow recreational marijuana on a nationwide level will be enormous.

Dozens of companies that have previously supplied only medical cannabis in Canada anticipate a surge in revenue.

Medical marijuana producer Sun Pharm Investments Ltd. is moving to create Zenabis Global Inc., a publicly-traded company with growing operations in British Columbia, New Brunswick, and eventually in Nova Scotia.

The privately-held cannabis company is merging with a subsidiary of propagated agricultural plants supplier Bevo Agro Inc. via reverse takeover, in which a smaller firm takes over a public company.

Just upriver from downtown Montreal, the Kahnawake First Nation council office takes pride of place in the reserve’s modest skyline, along with a youth centre and a pair of churches.

Soon, however, these old edifices may all be dwarfed by a sprawling, state-of-the-art greenhouse sprouting with cannabis plants and buzzing with cultivators of Canada’s newest legal commodity.

The Mohawk Council of Kahnawake has signed a non-binding agreement with Canopy Growth Corp. The potential deal would see the First Nation host a 4,650-square-metre production facility, plus a processing and packaging space nearly half that size, in partnership with Canada’s largest cannabis company.

Pot stocks are extremely expensive, and most investors know this. The question is: just how expensive and/or valuable are these securities?

In an attempt to conquer my thirst for curiosity with respect to marijuana stocks, I decided to dive into just how valuable these companies are relative to the entire Toronto Stock Exchange. The numbers are staggering.

Below is a chart of Canada’s top nine marijuana producers by market capitalization (as of time of writing):

You've probably heard Tilray (NASDAQ:TLRY) mentioned or read about the stock more times than you can keep track of over the last few weeks.

The marijuana stock's phenomenal rise, fall, and rebound have certainly attracted plenty of attention. 

Tilray's performance has made Auxly Cannabis Group's (NASDAQOTH:CBWTF) year-to-date gain of around 25% seem puny in comparison. Auxly definitely hasn't gotten even a fraction of the hype that Tilray has.

But which is the better marijuana stock now? Here's a quick look at how Tilray and Auxly stack up against each other.